Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
No Thumbnail Available
Issue Date
2013
Our author(s)
Davidson, N.
Department
Keywords
Language
English
Publisher
Elsevier
ISSN
1569-8041
0923-7534
0923-7534
eISSN
ISBN
Type
Article
Citation
Coleman, R., De Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., Von Minckwitz, G., Sleeboom, H. P., Forbes, J., Barrios, C., Frassoldati, A., Campbell, I., Paija, O., Martin, N., Modi, A. & Bundred, N. 2013. Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Annals of oncology : official journal of the European Society for Medical Oncology, 24, (2) 398-405.